NCT04635800 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients Status COMPLETED Phase PHASE1
NCT04632927 Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment Status COMPLETED Phase PHASE3
NCT04632056 A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD Status COMPLETED Phase N/A
NCT04630158 Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) Status COMPLETED Phase PHASE2
NCT04623216 Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation. Status TERMINATED Phase PHASE1/PHASE2
NCT04614831 A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis Status COMPLETED Phase N/A
NCT04609592 Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery Status RECRUITING Phase PHASE1
NCT04603495 Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04597632 An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study Status COMPLETED Phase PHASE3
NCT04593927 Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients Status COMPLETED Phase N/A
NCT04589663 Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma Status COMPLETED Phase PHASE2
NCT04589650 Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04587622 Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT04582409 A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation Status TERMINATED Phase PHASE2
NCT04581343 A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients Status COMPLETED Phase PHASE1
NCT04578834 Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients Status COMPLETED Phase PHASE3
NCT04573920 Atrasentan in Patients With Proteinuric Glomerular Diseases Status ACTIVE_NOT_RECRUITING Phase PHASE2